Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19
Overview
The purpose of this study is to determine whether patients with COVID-19 improve faster if they receive plasma from those who have recovered from COVID-19, because it may have the ability to fight the virus that causes COVID-19.
Description
Participants will receive plasma from a person who has recovered from COVID-19 with a compatible blood type.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
COVID-19
-
Age: Between 18 Years - 100 Years
-
Gender: All
Individuals at least 18 years of age with a laboratory confirmed diagnosis of COVID-19, with severe or life threatening disease.
Updated on
18 Apr 2024.
Study ID: 2004191377